Medical Device CDMO Market Size & Growth Forecast 2027–2036, By Segments (Product, Class, End Use, Service, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Medical Device CDMO Market size was more than USD 149.7 billion in 2026 and is set to grow at a 13.62% CAGR between 2027 and 2036, attaining USD 536.75 billion by 2036. The industry revenue for 2027 is estimated at USD 167.35 billion.
Get more details on this report
Request Free Sample ReportMedical Device CDMO Market Intelligence Snapshot
Regional Market Dynamics
- North America held 51.3% market share in 2026, supported by advanced manufacturing capabilities, strong healthcare infrastructure, and demand for specialized engineering, regulatory support, and faster commercialization.
- Asia Pacific is expected to grow fastest as healthcare investments, expanding manufacturing capabilities, and rising demand for outsourced production create opportunities for specialized medical device development and manufacturing services.
Segment Momentum
- Therapeutics accounted for 54.51% of the market in 2026, driven by demand for specialized engineering, validation, regulatory support, and scalable manufacturing that helps device developers accelerate commercialization and focus on innovation.
- OEMs are the largest and fastest-growing end-user segment, increasingly outsourcing engineering, manufacturing, quality assurance, and regulatory activities to access specialized capabilities, control production costs, and improve development flexibility.
Market Expansion Drivers
- Increasing medical device outsourcing to CDMOs.
- Growth of specialized and complex medical devices requiring CDMO support.
- Advancements in regulatory-compliant manufacturing technologies.
Leading Market Participants
- Prominent companies in the medical device CDMO market include Lonza (Switzerland), WuXi AppTec (China), Jabil (United States), Flex (Singapore), Integer Holdings (United States), Sanmina (United States), Plexus (United States), Gerresheimer (Germany), TE Connectivity (Switzerland).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 149.7 billion
- 2027 Estimated Market Size: USD 167.35 billion
- Projected Market Size: USD 536.75 billion by 2036
- Growth Forecast: 13.62% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Product (Therapeutics) | Class (Class II) | End Use (Original Equipment Manufacturers (OEMs)) | Service (Contract Manufacturing) | Application (Cardiovascular Devices)
- Emerging Opportunity Segment: Product (Therapeutics) | Class (Class II) | End Use (Original Equipment Manufacturers (OEMs)) | Service (Contract Manufacturing) | Application (Cardiovascular Devices)
Market Growth Drivers and Industry Trends
Increasing Medical Device Outsourcing to CDMOs
The increasing outsourcing of medical device manufacturing to contract development and manufacturing organizations is being driven by manufacturers seeking greater operational flexibility, specialized expertise, and access to advanced production capabilities. Outsourcing enables medical device developers to focus on product development and commercialization while relying on external partners for engineering, prototyping, manufacturing, testing, and quality management activities. It also helps manufacturers address evolving production requirements without making extensive investments in dedicated infrastructure and technical resources. As medical device development becomes more complex and manufacturers prioritize efficiency across the product lifecycle, demand for specialized CDMO services is expected to strengthen.
Growth of Specialized and Complex Medical Devices Requiring CDMO Support
The growing development of specialized and complex medical devices is creating greater demand for CDMOs with expertise in advanced engineering, precision manufacturing, and integrated product development. Devices incorporating sophisticated components, miniaturized designs, connected technologies, and specialized materials often require highly controlled manufacturing processes and multidisciplinary technical capabilities. CDMOs can provide access to specialized equipment, engineering knowledge, testing capabilities, and scalable production infrastructure, allowing device developers to manage complex manufacturing requirements more effectively. As innovation continues to expand across therapeutic and diagnostic applications, the need for specialized outsourcing support is expected to increase.
Advancements in Regulatory-Compliant Manufacturing Technologies
Advancements in regulatory-compliant manufacturing technologies are supporting the expansion of medical device CDMO services by enabling more consistent, traceable, and controlled production processes. Modern manufacturing systems increasingly incorporate automated quality controls, digital documentation, process monitoring, and advanced validation techniques to meet stringent requirements across the medical device lifecycle. These capabilities can help manufacturers strengthen quality management while reducing operational complexity associated with regulatory compliance. As regulatory expectations continue to evolve and device manufacturers place greater emphasis on quality and traceability, CDMOs with advanced compliant manufacturing capabilities are gaining importance.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing medical device outsourcing to CDMOs | 6% | Short term (≤ 2 yrs) | North America; Europe; Spillover: Asia Pacific | Medium | Fast |
| Growth of specialized and complex medical devices requiring CDMO support | 4.5% | Medium term (2–5 yrs) | North America; Europe; Spillover: Asia Pacific | Low | Moderate |
| Advancements in regulatory-compliant manufacturing technologies | 3% | Long term (5+ yrs) | North America; Asia Pacific | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share of the medical device CDMO market in 2026, accounting for 51.3% share in 2026, driven by the region’s advanced medical device manufacturing ecosystem, strong healthcare infrastructure, and increasing outsourcing of product development and manufacturing activities. The presence of sophisticated regulatory frameworks, growing demand for specialized medical technologies, and increasing complexity of medical device development are encouraging manufacturers to collaborate with contract development and manufacturing organizations. In addition, rising demand for cost-efficient production, faster commercialization, specialized engineering capabilities, and regulatory support is strengthening the adoption of CDMO services across the region. Increasing development of complex and technologically advanced medical devices is also creating demand for specialized manufacturing, testing, quality management, and product development capabilities.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to grow at the fastest pace in the medical device CDMO market, supported by expanding healthcare infrastructure, increasing medical device manufacturing capabilities, and rising demand for outsourced production services. Growing healthcare expenditure and increasing adoption of advanced medical technologies are encouraging the development of local manufacturing and product development ecosystems. In addition, the availability of skilled manufacturing capabilities, increasing investments in healthcare and medical technology, and growing efforts to establish efficient supply chains are creating opportunities for CDMO providers across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Innovation-to-Scale PartneringThe U.S. medical device CDMO market is centered on helping developers move complex products from design and prototyping into regulated commercial production. Demand favors partners with integrated engineering, manufacturing, quality, and supply-chain capabilities that can reduce development handoffs and support increasingly sophisticated device portfolios.
Germany 🇩🇪
Precision Manufacturing PartnershipsGermany's medical device CDMO market is supported by demand for high-precision engineering and manufacturing across technically demanding device categories. Customers prioritize partners that combine specialized production capabilities with rigorous quality systems, regulatory expertise, and dependable process control throughout product industrialization and commercial manufacturing.
Japan 🇯🇵
Quality-Centered OutsourcingJapan emphasizes manufacturing quality, process reliability, and long-term supplier relationships in medical device outsourcing. CDMOs serving the country need to support stringent production standards while offering engineering flexibility for advanced devices, helping domestic and international manufacturers manage product development, validation, and controlled manufacturing operations.
South Korea 🇰🇷
Integrated Device IndustrializationSouth Korea is strengthening its role in technology-intensive medical device production, increasing demand for CDMOs that connect design support with scalable manufacturing. Customers value partners able to provide prototyping, component production, assembly, and quality management while supporting faster commercialization of innovative and digitally enabled devices.
France 🇫🇷
Specialized Development SupportFrance's medical device CDMO market is shaped by demand for specialized engineering and manufacturing support, particularly for companies developing differentiated healthcare technologies. CDMO partnerships increasingly focus on bridging product development and regulated production, with customers seeking technical expertise, quality assurance, and flexible capacity for smaller or specialized programs.
Italy 🇮🇹
Flexible Production ExpertiseItaly offers a strong environment for specialized medical device manufacturing, with demand for flexible CDMO partners serving diverse product and component requirements. Customers prioritize engineering responsiveness, efficient production of specialized devices, and quality systems that support collaboration between manufacturers, technology developers, and international healthcare markets.
Medical Device CDMO Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Therapeutics (Largest & Fastest-Growing Segment)
The therapeutics segment accounted for the largest 2026 share of 54.51% of the medical device CDMO market by product and is also expected to register the fastest growth, driven by increasing demand for specialized manufacturing support across the development and commercialization of therapeutic medical devices. Medical device companies are increasingly relying on contract development and manufacturing partners to access specialized engineering capabilities, production expertise, quality systems, and regulatory support without building all capabilities internally. The growing complexity of therapeutic devices is encouraging manufacturers to seek external partners with expertise in design transfer, prototyping, process development, validation, and scalable production. In addition, rising demand for advanced treatment solutions and the need to accelerate product development are strengthening the role of CDMOs throughout the medical device lifecycle. Greater outsourcing of manufacturing activities can also help device developers improve operational flexibility while focusing internal resources on innovation, clinical development, and market expansion.
Class Segment Analysis: Class II (Largest & Fastest-Growing Segment)
Class II devices represent the largest segment of the medical device CDMO market by class and are also expected to experience the fastest growth, supported by the broad range of moderately regulated medical devices that require specialized development and manufacturing capabilities. These devices span numerous applications and often require contract partners to provide support across design engineering, component manufacturing, assembly, testing, packaging, and regulatory compliance. The increasing complexity of class II devices is encouraging manufacturers to collaborate with CDMOs that can provide integrated capabilities throughout the product lifecycle. Outsourcing also enables device developers to access specialized manufacturing infrastructure and quality management systems while reducing the need for significant internal investment. As healthcare providers and patients increasingly adopt technologically advanced diagnostic, monitoring, and therapeutic devices, demand for reliable and scalable manufacturing partnerships is supporting continued expansion of the class II segment.
End Use Segment Analysis: Original Equipment Manufacturers (OEMs) (Largest & Fastest-Growing Segment)
Original equipment manufacturers (OEMs) account for the largest segment of the medical device CDMO market by end use and are also expected to register the fastest growth, driven by the increasing adoption of outsourced development and manufacturing models among medical device manufacturers. OEMs are turning to CDMOs to obtain specialized engineering, manufacturing, quality assurance, regulatory, and supply chain capabilities while maintaining greater focus on product innovation and commercial activities. This approach is particularly valuable as medical devices become more technologically sophisticated and require tighter integration of materials, electronics, software, precision components, and manufacturing processes. Contract manufacturing partnerships can also provide OEMs with greater production flexibility when launching new products or responding to changing demand. Increasing pressure to control production costs, shorten development timelines, and maintain stringent quality standards is further encouraging OEMs to expand their reliance on external manufacturing specialists, supporting sustained demand for comprehensive CDMO services.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Diagnostics, Therapeutics, Drug-Device Combination Products | Therapeutics | Therapeutics |
| Class | Class I, Class II, Class III | Class II | Class II |
| End Use | Original Equipment Manufacturers (OEMs), Pharmaceutical & Biopharmaceutical Companies, Others | Original Equipment Manufacturers (OEMs) | Original Equipment Manufacturers (OEMs) |
| Service | Contract Development, Contract Manufacturing, Packaging, Regulatory Affairs, Others | Contract Manufacturing | Contract Manufacturing |
| Application | Cardiovascular Devices, Orthopedic Devices, Ophthalmic Devices, Diagnostic Devices, Respiratory Devices, Surgical Instruments, Dental, Others | Cardiovascular Devices | Cardiovascular Devices |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
The medical device CDMO market is shaped by the ability to combine regulatory expertise, specialized manufacturing infrastructure, and dependable supply chain management throughout the product lifecycle. Turnkey design and regulatory services help device developers coordinate product development and manufacturing preparation, but require clear accountability and traceable documentation because outsourcing does not transfer the manufacturer's regulatory responsibilities. Precision manufacturing, validated cleanroom environments, and specialized assembly capabilities provide further differentiation, particularly for complex and higher-risk devices requiring stringent process controls and traceability. At the same time, component shortages and logistical disruptions reinforce the importance of qualified suppliers, alternative sourcing, and inventory planning. CDMOs that align technical capabilities with production requirements and supply continuity can strengthen client relationships without incurring unnecessary costs through excessive vertical integration.
Major players in the medical device CDMO market:
- Lonza (Switzerland)
- WuXi AppTec (China)
- Jabil (United States)
- Flex (Singapore)
- Integer Holdings (United States)
- Sanmina (United States)
- Plexus (United States)
- Gerresheimer (Germany)
- TE Connectivity (Switzerland)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Lonza (Switzerland) | |||||||
| WuXi AppTec (China) | |||||||
| Jabil (United States) | |||||||
| Flex (Singapore) | |||||||
| Integer Holdings (United States) | |||||||
| Sanmina (United States) | |||||||
| Plexus (United States) | |||||||
| Gerresheimer (Germany) | |||||||
| TE Connectivity (Switzerland) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cordica Medical | June 2026 | Cordica Medical acquired the micro-molding operations of RapidWerks, integrating fully automated mass-production micro-molding capabilities into its CDMO platform. The acquisition strengthens high-precision manufacturing capacity for OEM clients requiring scalable, intricate medical components. |
| Nissha | May 2026 | Nissha constructed a dedicated manufacturing facility to expand micro-molding capacity for precision medical devices. The capital investment enhances core component fabrication infrastructure to support increasing global demand for high-accuracy molded parts. |
| Arterex | April 2026 | Arterex expanded its Boston-area manufacturing facility, driving a 50% increase in operational capacity. The infrastructure investment significantly scales the CDMO's regional footprint to accommodate growing production requirements from medical device clients. |
| Sanmina | November 2025 | Sanmina expanded its medical manufacturing facility in Fermoy, Ireland, incorporating advanced automation lines, an ISO Class 8 cleanroom, and high-volume wearable device production capabilities. The investment expands European finished device manufacturing infrastructure and creates up to 150 skilled technical roles. |
| Forj Medical | October 2025 | Intricon and Minnetronix merged to establish Forj Medical, forming a fully integrated development and manufacturing CDMO. The combination unifies device engineering and scalable production capabilities, enhancing end-to-end support for medical device OEMs commercializing complex technologies. |
| Sanner | July 2025 | Sanner established its first U.S. manufacturing facility in Greensboro, North Carolina, expanding its transatlantic CDMO and healthcare packaging footprint. The site expansion follows strategic M&A activity to support localized production for North American clients. |
| Salt Medical | April 2025 | Salt Medical opened a manufacturing facility at Claregalway Corporate Park, dedicated to the development and production of minimally invasive devices. The operational footprint expansion builds manufacturing capacity to support specialized medical device contract clients. |
| Flex | March 2025 | Flex opened a healthcare-dedicated New Product Introduction Center near Boston, Massachusetts, offering end-to-end capabilities from prototyping to production transfer. The facility enhances acceleration to market and scalable manufacturing support for medical device creators. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Medical Device CDMO Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Development Stage | Preclinical/Concept Development, Clinical Development, Commercial Production, Post-Market/Lifecycle Support |
| Production Scale | Prototype/Small Batch, Pilot/Medium Scale, Commercial/Large Scale |
| Client Engagement Model | Project-Based, Fee-for-Service, Dedicated Capacity/Strategic Partnership |
Medical Device CDMO Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Outsourcing Decision Frameworks |
|
| Quality & Regulatory Risk Management |
|
| Sponsor-to-CDMO Transition Dynamics |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How much is the medical device CDMO market worth?
How is the medical device CDMO industry projected to perform over the next decade?
How is increasing outsourcing reshaping demand for medical device CDMO services?
Why are advanced manufacturing technologies becoming strategically important for medical device CDMOs?
Why do therapeutics lead the medical device CDMO market?
How are OEMs driving growth in the medical device CDMO market?
Why does North America lead the medical device CDMO market?
What is driving medical device CDMO market growth in Asia Pacific?
Who are the leading players in the medical device CDMO landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook